GL1X · GenesisL1 explorer

MolNFT v1 · #136438 · protein

JAK2 JH2 in complex with ikk-2 inhibitor VI

5UT3 · Tyrosine-protein kinase JAK2: “JAK2 JH2 in complex with ikk-2 inhibitor VI”. X-ray diffraction, 1 ligand (IK1), 2 pockets (best druggability 0.66). MolNFT v1 #136438 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5UT3
Type
protein
Length
272 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
IK1
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein27244% helix, 21% strandO60674

Ligands and binding sites

  • IK1 · 5-phenyl-2-ureidothiophene-3-carboxamide · ligand · chains A
  • GOL · Glycerol · additive · 3 copies · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13760.660.8038IK1, GOL, ACT
2730.390.7917empty

Compared structures

  • 5UT3 · JAK2 JH2 in complex with IKK-2 Inhibitor VI · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.